Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 Contact Hours.

Acknowledgment of Support

This activity is supported by educational grants from AstraZeneca; Exact Sciences Corporation; Eisai Inc.; Genomic Health; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Seattle Genetics, Inc

2nd Annual Precision Medicine Symposium: An Illustrated Tumor Board

Release Date: November 30, 2020
Expiration Date: November 30, 2021

Activity Overview

This online educational activity is designed to provide expert commentary regarding the role of precision medicine in major solid and liquid tumors, including lung cancers, breast cancers, gastrointestinal cancers, genitourinary cancers, skin cancers, and hematologic malignancies. The latest updates in next-generation sequencing, liquid biopsy, and cytogenetic testing will be discussed. This activity will emphasize the role of advanced genetic panel testing and the use of targeted therapies, as well as best practices for leveraging relevant actionable targets that drive clinical decision-making, with a focus on data that is most relevant for patient care. This activity is presented in a multimedia format that includes a series of video interviews with expert thought leaders integrated into text-based elements.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca; Exact Sciences Corporation; Eisai Inc.; Genomic Health; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Seattle Genetics, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational activity is directed toward pathologists and oncologists, as well as nurses and fellows, involved in the treatment and management of patients with cancer. Physician assistants, pharmacists, researchers, and other health care professionals may also participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Learn from the experts how to interpret tumor pathology reports to facilitate evidence-based treatment across malignancies
  • Improve your knowledge about diagnostic and treatment-related data relevant to optimal multidisciplinary care
  • Gain expert perspectives on the most relevant data regarding the current and evolving role of genomic assays in cancer management
  • Learn about the latest clinical data regarding the use of biomarkers in qualifying patients for specific oncolytic therapies

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
Leslye M. Heisler Associate Professor for Lung Cancer Excellence
Hospital of the University of Pennsylvania
Philadelphia, PA

Disclosures:Grant/Research Support: Macrogenics, Merck & Co, AstraZeneca; Consultant: AstraZeneca, Bristol Myers Squibb, Celgene, Eli Lilly and Company, Genentech.

Matthew S. Davids, MD, MMSc
Matthew S. Davids, MD, MMSc M. Brenner, ND, FACG, AGAF
Assistant Professor of Medicine, Harvard Medical School
Associate Director, Center for Chronic Lymphocytic Leukemia
Boston, MA

Disclosures: Grant/Research Support: AbbVie, Ascentage Pharma, AstraZeneca, Genentech, MEI Pharma, Novartis, Pharmacyclics, Surface Oncology, TG Therapeutics, Verastem Oncology; Consultant: AbbVie, Adaptive Biotechnologies, Ascentage Pharma, AstraZeneca, BeiGene, Celgene, Eli Lilly and Company, Genentech, Janssen Pharmaceuticals, MEI Pharma, Merck & Co, Novartis, Pharmacyclics, Research to Practice, TG Therapeutics, Verastem Oncology.

Tatyana A. Feldman, MD
Tatyana A. Feldman, MD
Director, T-Cell Lymphoma Program
John Theurer Cancer Center
Hackensack University Medical Center
Hackensack, NJ

Disclosures: Consultant: Celgene/Bristol Myers Squibb, Karyopharm, Kite Pharma, Seattle Genetics; Speakers’ Bureau: AbbVie, Celgene/Bristol Myers Squibb, Janssen Pharmaceuticals, Kite Pharma, Seattle Genetics, Takeda Pharmaceutical Company.

Benjamin P. Levy, MD
Benjamin P. Levy, MD
Associate Professor, Johns Hopkins School of Medicine
Clinical Director of Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC

Disclosures: Consultant: AstraZeneca, Celgene, Merck & Co., Inc., Eli Lilly and Company, Genentech, Takeda Pharmaceutical Company.

Stanley E. Waintraub, MD
Stanley E. Waintraub, MD
Co-Chief, Division of Breast Oncology
Chief, Division of Hematology
John Theurer Cancer Center
Hackensack, NJ

Disclosures: Shareholder: Bristol Myers Squibb.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
   1234
567891011
12131415161718
19202122232425
262728293031
Filter By